$ALTO
Alto Ingredients, Inc. Stock $alto

$alto Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022070278 Filed on November 09, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$328.4M	$336.9M	$305.6M
YoY Change	-14.8%	10.25%	49.27%
Cost Of Revenue	$349.8M	$356.7M	$309.0M
YoY Change	1.86%	15.46%	68.09%
Gross Profit	-$21.33M	-$19.84M	-$3.399M
YoY Change	-150.64%	483.67%	-116.26%
Gross Profit Margin	-6.49%	-5.89%	-1.11%
Selling, General & Admin	$7.551M	$7.403M	$5.533M
YoY Change	-19.74%	33.8%	-13.55%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.973M	$6.260M	$5.850M
YoY Change	3.48%	7.01%	-27.33%
% of Gross Profit
Operating Expenses	$7.551M	$7.403M	$5.533M
YoY Change	-19.74%	33.8%	-14.88%
Operating Profit	-$28.88M	-$27.24M	-$8.932M
YoY Change	-188.3%	204.99%	-162.03%
Interest Expense	-$968.0K	-$340.0K	-$429.0K
YoY Change	324.56%	-20.75%	-96.14%
% of Operating Profit
Other Income/Expense, Net	$930.0K	-$456.0K	$256.0K
YoY Change	64.02%	-278.13%
Pretax Income	-$31.15M	-$28.04M	-$3.132M
YoY Change	-182.8%	795.21%	-120.61%
Income Tax	$1.925M		$0.00
% Of Pretax Income
Net Earnings	-$33.39M	-$28.04M	-$3.132M
YoY Change	-192.38%	795.21%	-120.61%
Net Earnings / Revenue	-10.17%	-8.32%	-1.03%
Basic Earnings Per Share		-$0.39	-$0.05
Diluted Earnings Per Share	-$0.46	-$0.39	-$43.88K
COMMON SHARES
Basic Shares Outstanding	73.96M shares	74.18M shares	71.38K shares
Diluted Shares Outstanding		73.01K shares	71.38K shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$36.46M	$28.46M	$36.03M
YoY Change	-27.97%	-21.01%	-6.9%
Cash & Equivalents	$36.46M	$28.46M	$36.03M
Short-Term Investments
Other Short-Term Assets	$9.340M	$8.966M	$54.03M
YoY Change	30.16%	-83.4%	221.6%
Inventory	$66.63M	$61.09M	$58.12M
Prepaid Expenses
Receivables	$68.66M	$76.46M	$78.42M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$199.1M	$186.3M	$226.6M
YoY Change	-13.25%	-17.78%	64.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$239.1M	$233.5M	$237.0M
YoY Change	7.42%	-1.5%	-27.73%
Goodwill	$5.970M	$5.970M
YoY Change
Intangibles	$9.087M
YoY Change	239.32%
Long-Term Investments
YoY Change
Other Assets	$6.137M	$6.788M	$4.671M
YoY Change	19.28%	45.32%	-15.07%
Total Long-Term Assets	$279.2M	$268.4M	$256.8M
YoY Change	9.31%	4.5%	-27.0%
TOTAL ASSETS
Total Short-Term Assets	$199.1M	$186.3M	$226.6M
Total Long-Term Assets	$279.2M	$268.4M	$256.8M
Total Assets	$478.3M	$454.7M	$483.4M
YoY Change	-1.37%	-5.94%	-1.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.12M	$17.49M	$28.39M
YoY Change	20.92%	-38.38%	61.29%
Accrued Expenses	$26.56M	$22.17M	$18.67M
YoY Change	24.64%	18.75%	30.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$17.69M
YoY Change			-76.39%
Total Short-Term Liabilities	$78.02M	$54.51M	$84.45M
YoY Change	12.09%	-35.45%	-26.63%
LONG-TERM LIABILITIES
Long-Term Debt	$68.36M	$45.89M	$70.62M
YoY Change	35.73%	-35.02%	-19.75%
Other Long-Term Liabilities	$8.797M	$10.07M	$23.14M
YoY Change	-15.36%	-56.49%	-43.84%
Total Long-Term Liabilities	$77.15M	$55.96M	$93.76M
YoY Change	26.99%	-40.32%	-27.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$78.02M	$54.51M	$84.45M
Total Long-Term Liabilities	$77.15M	$55.96M	$93.76M
Total Liabilities	$170.2M	$119.7M	$178.2M
YoY Change	21.82%	-32.85%	-27.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$734.6M	-$701.3M
YoY Change	6.2%
Common Stock	$75.00K	$74.00K
YoY Change	2.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$308.1M	$335.0M	$305.2M
YoY Change
Total Liabilities & Shareholders Equity	$478.3M	$454.7M	$483.4M
YoY Change	-1.37%	-5.94%	-1.25%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$33.39M	-$28.04M	-$3.132M
YoY Change	-192.38%	795.21%	-120.61%
Depreciation, Depletion And Amortization	$5.973M	$6.260M	$5.850M
YoY Change	3.48%	7.01%	-27.33%
Cash From Operating Activities	$4.209M	-$18.86M	-$23.77M
YoY Change	-90.96%	-20.67%	-179.15%
INVESTING ACTIVITIES
Capital Expenditures	$12.51M	-$15.47M	-$8.048M
YoY Change	-401.91%	92.23%	242.47%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$14.74M	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$12.51M	-$735.0K	-$8.048M
YoY Change	-163.01%	-90.87%	241.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	25.41M	-22.73M	13.79M
YoY Change	-162.21%	-264.83%	-173.64%
NET CHANGE
Cash From Operating Activities	4.209M	-18.86M	-23.77M
Cash From Investing Activities	-12.51M	-735.0K	-8.048M
Cash From Financing Activities	25.41M	-22.73M	13.79M
Net Change In Cash	17.11M	-42.32M	-18.02M
YoY Change	-33.09%	134.82%	-301.61%
FREE CASH FLOW
Cash From Operating Activities	$4.209M	-$18.86M	-$23.77M
Capital Expenditures	$12.51M	-$15.47M	-$8.048M
Free Cash Flow	-$8.302M	-$3.384M	-$15.72M
YoY Change	-116.37%	-78.47%	-148.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	86888000	usd
CY2022Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	alto	Common Stock Value One CommonStockValueOne		usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2022Q3	alto	Common Stock Value One CommonStockValueOne		usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	69602000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50361000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9382000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10394000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	139739000	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-21467
	dei	Entity Registrant Name EntityRegistrantName	ALTO INGREDIENTS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-2170618
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1300 South Second Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Pekin
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	61554
	dei	City Area Code CityAreaCode	(916)
	dei	Local Phone Number LocalPhoneNumber	403-2123
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	ALTO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	73956108	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28458000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	3955000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	135000	usd
CY2022Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	76455000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	61088000	usd
CY2022Q3	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	7384000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3125000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	8966000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7176000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	186306000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	229526000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	233475000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	222550000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12895000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13413000	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	11641000	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	9234000	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	2678000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	5970000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6788000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5145000	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	34887000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	32877000	usd
CY2022Q3	us-gaap	Assets Assets	454668000	usd
CY2021Q4	us-gaap	Assets Assets	484953000	usd
CY2022Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	17493000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	23251000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	22172000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21307000	usd
CY2022Q3	alto	Current Portion Operating Leases CurrentPortionOperatingLeases	3646000	usd
CY2021Q4	alto	Current Portion Operating Leases CurrentPortionOperatingLeases	3909000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1106000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13582000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10096000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7553000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	54513000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	45888000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9201000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10068000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	119670000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73956000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73956000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	74000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1036459000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-284000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-701252000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	334998000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	345214000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	454668000	usd
CY2022Q3	us-gaap	Revenues Revenues	336877000	usd
CY2021Q3	us-gaap	Revenues Revenues	305556000	usd
	us-gaap	Revenues Revenues	1007184000	usd
	us-gaap	Revenues Revenues	822400000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	356716000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	308955000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1013406000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	796729000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-19839000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	-3399000	usd
	us-gaap	Gross Profit GrossProfit	-6222000	usd
	us-gaap	Gross Profit GrossProfit	25671000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7403000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5533000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24028000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19777000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3100000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-27242000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8932000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-30250000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2794000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-340000	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-429000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.13
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-859000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3359000	usd
	us-gaap	Interest Income Other InterestIncomeOther	22652000	usd
CY2021Q3	alto	Income From Loan Forgiveness IncomeFromLoanForgiveness	-5973000	usd
	alto	Income From Loan Forgiveness IncomeFromLoanForgiveness	-9860000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-456000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	256000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-68000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	641000	usd
CY2022Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-28038000	usd
CY2021Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-3132000	usd
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-8525000	usd
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	9936000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-28038000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-3132000	usd
	us-gaap	Profit Loss ProfitLoss	-8525000	usd
	us-gaap	Profit Loss ProfitLoss	9936000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	319000	usd
CY2021Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	319000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	946000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	946000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	120000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28357000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3451000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9471000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8870000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73011	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71383	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71815	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71002	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73011	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71383	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71815	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72260	shares
	us-gaap	Profit Loss ProfitLoss	-8525000	usd
	us-gaap	Profit Loss ProfitLoss	9936000	usd
	us-gaap	Depreciation Depreciation	19122000	usd
	us-gaap	Depreciation Depreciation	17520000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.12
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	72764	shares
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	7963000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3100000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	9860000	usd
	alto	Shares Based Compensation SharesBasedCompensation	2546000	usd
	alto	Shares Based Compensation SharesBasedCompensation	2283000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	29000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	732000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-187000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	140000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16137000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35072000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	13290000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	20192000	usd
	alto	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	-7472000	usd
	alto	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	8011000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3799000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3184000	usd
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	2874000	usd
	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-1467000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10684000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8482000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1840000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19511000	usd
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	14766000	usd
	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	19500000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25233000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12240000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	14685000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25152000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7260000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-4452000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	38198000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1002000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	462000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	37810000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	946000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6400000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	850000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29712000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11401000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62125000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48187000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32413000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36786000	usd
	alto	Cash And Cash Equivalents CashAndCashEquivalents	28458000	usd
	alto	Cash And Cash Equivalents CashAndCashEquivalents	36029000	usd
	alto	Total Cash Cash Equivalents And Restricted Cash TotalCashCashEquivalentsAndRestrictedCash	32413000	usd
	alto	Value Of Restricted Cash ValueOfRestrictedCash	3955000	usd
	alto	Value Of Restricted Cash ValueOfRestrictedCash	757000	usd
	alto	Total Cash Cash Equivalents And Restricted Cash TotalCashCashEquivalentsAndRestrictedCash	36786000	usd
	us-gaap	Interest Paid Net InterestPaidNet	961000	usd
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	73209	shares
	us-gaap	Interest Paid Net InterestPaidNet	3194000	usd
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	946000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	345214000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-9000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	673000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	312000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2602000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	342965000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2283000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1106000	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	315000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	22115000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	363588000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1002000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	767000	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	319000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-28038000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	334998000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	296235000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-185000	usd
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	804000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	462000	usd
CY2021Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	312000	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	4678000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	301682000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2589000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	851000	usd
CY2021Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	315000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	8390000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	308019000	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	628000	usd
CY2021Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	319000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-3132000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	305196000	usd
	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	350000000	usd
CY2022Q3	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	1500000	usd
	us-gaap	Intermediate Life Plants Useful Life IntermediateLifePlantsUsefulLife	P12Y
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	964000	shares
	alto	Loan Advance LoanAdvance	700000000	usd
	us-gaap	Accounts Receivable Sale AccountsReceivableSale	54972000	usd
CY2021	us-gaap	Accounts Receivable Sale AccountsReceivableSale	63929000	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	135000	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	378000	usd
CY2022Q3	alto	Bad Debt Expense BadDebtExpense	253000	usd
CY2021Q3	alto	Bad Debt Expense BadDebtExpense	3000	usd
	alto	Bad Debt Expense BadDebtExpense	187000	usd
	alto	Bad Debt Expense BadDebtExpense	140000	usd
CY2022Q3	us-gaap	Cash Cash	22652000	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	8474000	usd
CY2022Q3	alto	Repurchase Of Common Stock RepurchaseOfCommonStock	50000000	usd
CY2022Q3	alto	Excess Amount Of Initial Purchase ExcessAmountOfInitialPurchase	10000000	usd
CY2022Q3	alto	Purchase Additional Amount PurchaseAdditionalAmount	10000000	usd
CY2022Q3	alto	Repurchased An Aggregate Shares In Cash RepurchasedAnAggregateSharesInCash	259000	usd
	alto	Repurchased An Aggregate Shares In Cash RepurchasedAnAggregateSharesInCash	1002000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Estimates and Assumptions</span></i> – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for doubtful accounts, net realizable value of inventory, estimated lives of property and equipment, long-lived asset impairments, fair value of warrants, valuation allowances on deferred income taxes, the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.</p>
CY2022Q1	alto	Purchased Membership Interests PurchasedMembershipInterests	1	pure
CY2022Q1	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	14000000	usd
CY2022Q1	alto	Net Working Capital NetWorkingCapital	1300000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	14000000	usd
CY2022Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	9000000	usd
CY2022Q1	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	5000000	usd
CY2022Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	900000	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	2600000	usd
CY2022Q3	us-gaap	Loans And Leases Receivable Gain Loss On Sales Net LoansAndLeasesReceivableGainLossOnSalesNet	4200000	usd
CY2021Q3	us-gaap	Loans And Leases Receivable Gain Loss On Sales Net LoansAndLeasesReceivableGainLossOnSalesNet	9900000	usd
CY2022Q3	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	0	usd
CY2021Q3	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	1000000	usd
	us-gaap	Loans And Leases Receivable Gain Loss On Sales Net LoansAndLeasesReceivableGainLossOnSalesNet	12100000	usd
	us-gaap	Loans And Leases Receivable Gain Loss On Sales Net LoansAndLeasesReceivableGainLossOnSalesNet	27500000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	100000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	3000000	usd
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	336877000	usd
CY2021Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	311821000	usd
CY2022Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-28357000	usd
CY2021Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-3424000	usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.38
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.05
CY2022Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	73960	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	72332	shares
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1007711000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	840947000	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-9538000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	137000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	390000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30000	usd
	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	20164000	usd
	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	18435000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	356716000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	308955000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1013406000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	796729000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-19839000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	-3399000	usd
	us-gaap	Gross Profit GrossProfit	-6222000	usd
	us-gaap	Gross Profit GrossProfit	25671000	usd
CY2022Q3	us-gaap	Assets Assets	454668000	usd
CY2021Q4	us-gaap	Assets Assets	484953000	usd
CY2022Q3	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	7963000	usd
CY2021Q4	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	0	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	40630000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	35509000	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	8084000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	6909000	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	11321000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10837000	usd
CY2022Q3	us-gaap	Other Inventory OtherInventory	1053000	usd
CY2021Q4	us-gaap	Other Inventory OtherInventory	1118000	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	61088000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	54373000	usd
CY2022Q3	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	1772000	usd
CY2021Q3	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	976000	usd
CY2021Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	40000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	964000	shares
CY2022Q3	us-gaap	Other Long Term Debt OtherLongTermDebt	45888000	usd
CY2021Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	50361000	usd
	alto	Type Of Instrument Cash Collateral Balance TypeOfInstrumentCashCollateralBalance	Cash collateral balance
	alto	Assets Balance Sheet Location Restrictedcashs AssetsBalanceSheetLocationRestrictedcashs	Restricted cash
CY2022Q3	alto	Assets Fair Value Restrictedcash AssetsFairValueRestrictedcash	3955000	usd
	alto	Type Of Instrument Commoditys Contracts1 TypeOfInstrumentCommoditysContracts1	Commodity contracts
	alto	Assets Balance Sheet Location Derivatives Assets AssetsBalanceSheetLocationDerivativesAssets	Derivative assets
CY2022Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	7384000	usd
	alto	Liabilities Balance Sheet Location Derivative Liabilities LiabilitiesBalanceSheetLocationDerivativeLiabilities	Derivative liabilities
CY2022Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	1106000	usd
CY2021	alto	Type Of Instrument Cash Collateral Balance TypeOfInstrumentCashCollateralBalance	Cash collateral balance
CY2021	alto	Assets Balance Sheet Location Restrictedcashs AssetsBalanceSheetLocationRestrictedcashs	Restricted cash
CY2021Q4	alto	Assets Fair Value Restrictedcash AssetsFairValueRestrictedcash	11513000	usd
CY2021	alto	Type Of Instrument Commoditys Contracts1 TypeOfInstrumentCommoditysContracts1	Commodity contracts
CY2021	alto	Assets Balance Sheet Location Derivatives Assets AssetsBalanceSheetLocationDerivativesAssets	Derivative assets
CY2021Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	15839000	usd
CY2021	alto	Liabilities Balance Sheet Location Derivative Liabilities LiabilitiesBalanceSheetLocationDerivativeLiabilities	Derivative liabilities
CY2021Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	13582000	usd
CY2022Q3	us-gaap	Unamortized Loss Reacquired Debt Noncurrent UnamortizedLossReacquiredDebtNoncurrent	45949000	usd
CY2021Q4	us-gaap	Unamortized Loss Reacquired Debt Noncurrent UnamortizedLossReacquiredDebtNoncurrent	50401000	usd
CY2022Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	61000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8870000	usd
	alto	Diluted Income Available To Common Stockholders DilutedIncomeAvailableToCommonStockholders	72260	shares
	alto	Diluted Income Available To Common Stockholders Per Share DilutedIncomeAvailableToCommonStockholdersPerShare	0.12
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	964000	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	964000	shares
CY2022Q3	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	30700000	usd
	alto	Indexedprice Purchase Contracts IndexedpricePurchaseContracts	92771000	pure
CY2022Q3	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	17274000	usd
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	46796000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1000000	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	36826000	usd
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-28038000	usd
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-319000	usd
CY2022Q3	alto	Incomeloss Available To Common Stockholders IncomelossAvailableToCommonStockholders	-28357000	usd
CY2022Q3	alto	Incomeloss Available To Common Stockholders In Shares IncomelossAvailableToCommonStockholdersInShares	73011	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2021Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-3132000	usd
CY2021Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-319000	usd
CY2021Q3	alto	Incomeloss Available To Common Stockholders IncomelossAvailableToCommonStockholders	-3451000	usd
CY2021Q3	alto	Incomeloss Available To Common Stockholders In Shares IncomelossAvailableToCommonStockholdersInShares	71383	shares
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-8525000	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-946000	usd
	alto	Incomeloss Available To Common Stockholders IncomelossAvailableToCommonStockholders	-9471000	usd
	alto	Incomeloss Available To Common Stockholders In Shares IncomelossAvailableToCommonStockholdersInShares	71815	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	9936000	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-946000	usd
	alto	Income Allocated To Participating Securities IncomeAllocatedToParticipatingSecurities	-120000	usd
	alto	Incomeloss Available To Common Stockholders IncomelossAvailableToCommonStockholders	8870000	usd
	alto	Incomeloss Available To Common Stockholders In Shares IncomelossAvailableToCommonStockholdersInShares	71002	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	alto	Dilutive Instruments DilutiveInstruments	1258	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	8900000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.76
CY2021Q4	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2022-04-28
CY2022Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2021Q3	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2022Q3	alto	Income From Loan Forgiveness IncomeFromLoanForgiveness		usd
	alto	Income From Loan Forgiveness IncomeFromLoanForgiveness		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic		usd
CY2021Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic		usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale		usd
	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale		usd
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt		usd
	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings		usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		usd
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount		usd
	alto	Liabilities Balance Sheet Location LiabilitiesBalanceSheetLocation
CY2022Q3	us-gaap	Fair Value Hedge Liabilities At Fair Value FairValueHedgeLiabilitiesAtFairValue		usd
CY2021	alto	Liabilities Balance Sheet Location LiabilitiesBalanceSheetLocation
CY2021Q4	us-gaap	Fair Value Hedge Liabilities At Fair Value FairValueHedgeLiabilitiesAtFairValue		usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
	us-gaap	Dilutive Securities DilutiveSecurities		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000778164

Files In Submission

Name	View Source	Status
0001213900-22-070278-index-headers.html	Edgar Link	pending
0001213900-22-070278-index.html	Edgar Link	pending
0001213900-22-070278.txt	Edgar Link	pending
0001213900-22-070278-xbrl.zip	Edgar Link	pending
alto-20220930.xsd	Edgar Link	pending
f10q0922ex31-1_altoingred.htm	Edgar Link	pending
f10q0922ex31-2_altoingred.htm	Edgar Link	pending
f10q0922ex32-1_altoingred.htm	Edgar Link	pending
f10q0922_altoingred.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
alto-20220930_lab.xml	Edgar Link	unprocessable
alto-20220930_def.xml	Edgar Link	unprocessable
alto-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0922_altoingred_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
alto-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALTO
Alto Ingredients, Inc. Stock $alto

2022 Q4 Form 10-Q Financial Statement

#000121390022070278 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO Alto Ingredients, Inc. Stock $alto

2022 Q4 Form 10-Q Financial Statement

#000121390022070278 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO
Alto Ingredients, Inc. Stock $alto